Cas:107328-14-3 2-(benzylamino)-4-(cyclohexylamino)-4-oxobutanoic acid manufacturer & supplier

Chemical Name:2-(benzylamino)-4-(cyclohexylamino)-4-oxobutanoic acid

CAS.NO:107328-14-3

Synonyms:N-Benzyl-DL-asparaginsaeure-4-cyclohexylamid;N2-benzyl-N4-cyclohexyl-asparagine;2-Benzylamino-N-cyclohexyl-succinamic acid

Molecular Formula:C₁₇H₂₄N₂O₃

Molecular Weight:304.38400

HS Code:2922499990

Physical and Chemical Properties:

Melting point:N/A

Boiling point:548.6ºC at 760mmHg

Density:1.17g/cm3

Index of Refraction:1.566

PSA:78.43000

Exact Mass:304.17900

LogP:2.85020

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like N-Benzyl-DL-asparaginsaeure-4-cyclohexylamid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Benzylamino-N-cyclohexyl-succinamic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,N2-benzyl-N4-cyclohexyl-asparagine Use and application,2-Benzylamino-N-cyclohexyl-succinamic acid technical grade,usp/ep/jp grade.

Related News: The company’s greenfield facility in Vasanthnarsapura Karnataka Industrial Area, Tumkur district, Karnataka, is under construction and is expected to be commissioned by April, 2022, well before the PLI scheme deadline of April 1, 2023. 3,4,5-trichloro-isothiazole manufacturers McNamara joined GSK from Novartis in 2015 when the two companies combined their OTC portfolios into a joint venture managed by GSK. He became head of GSK consumer health in 2016, taking the baton from Walmsley as she moved up the command chain to CEO of the entire group. Novartis in 2018 backed out of the collab, and after taking full control of the venture, GSK formed a new JV with Pfizer in 2019. 4-Pyridinecarboxylic acid, 2-[(diphosphonomethyl)amino]- suppliers Enzymes play a pivotal role in the catalysis of many different bio-transformation reactions in nature, typically exerting their effects under mild, neutral conditions. 4,5-diamino-1,2-dimethyl-6-oxo-1,6-dihydro-pyridine-3-carboxylic acid ethyl ester vendor & factory Dr. Elsie Melsopp, Head of Solids Formulations for Alcami, says the company successfully helped a client overcome an API supply shortage using Quality by Design (QbD) studies to successfully formulate an orphan drug product. ,McNamara joined GSK from Novartis in 2015 when the two companies combined their OTC portfolios into a joint venture managed by GSK. He became head of GSK consumer health in 2016, taking the baton from Walmsley as she moved up the command chain to CEO of the entire group. Novartis in 2018 backed out of the collab, and after taking full control of the venture, GSK formed a new JV with Pfizer in 2019.